Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
GNI Group surges after three-day decline on forecast of consecutive record-high sales for December 2026
GNI Group Ltd. <2160> surged after a three-day decline. After the close of trading on the 31st, the company disclosed only its sales forecast for the fiscal year ending December 2026, which had previously been undecided. The company projects sales of \27.158 billion for the current fiscal year, up 1.2% from the previous year. With sales expected to reach a record high for the second consecutive year, the stock attracted buying on growth expectations. The company stated that it has become possible to estimate sales with a certain degree of probability for its existing businesses, which are not affected by regulatory developments. From a conservative standpoint, the forecast does not incorporate sales contributions from the timing of new drug launches in the pharmaceutical business or the start of new businesses in the medtech segment.
Source: MINKABU PRESS
Related Articles
Sumasapo extends gains on acquisition of municipal solution business from T&C Technologies
CERES INC. continues to rise on announcement of subsidiary acquisition of online medical consultation platform operator SQUIZ
MCJ shares fall sharply for first time in 4 days as Bain Capital states no intention to raise TOB price
MIRAINI Holdings Surges on Planned \8.8 Billion Negative Goodwill Gain in Q1 FY03/27
KYORIN Pharma Surges on License Agreement with France's Biodol for Neuropathic Pain Drug Candidate
Minkabu Individual Investor Sentiment: Tokio Marine Ranks 4th in Rising Sell Predictions
Investment Money Flows into Defense-Related Stocks Including Mitsubishi Heavy as Global Geopolitical Risks Intensify, Triggering Fresh Buying
Nxera Pharma surges again, briefly hitting daily limit as partner Centessa to be acquired by Eli Lilly
JELLY BEANS Continues to Rise on Plans to Establish SPC for Recycled Heavy Oil Refinery Business Through Subsidiary
"Rare Earths" Ranks 3rd as Mitsubishi Materials Pursues Critical Minerals Recycling in U.S. - Featured Theme